BCIQ Profiles

Company Profile Report
0824 Plasma EUA
BioCentury & Getty Images

Regulation

Ex-FDA officials: EUA may be merited, but FDA put politics ahead of science

Former senior agency officials say Hahn prioritized politics in authorizing COVID-19 convalescent plasma

FDA Commissioner Stephen Hahn prioritized politics in his decisions and comments about granting Emergency Use Authorization for convalescent plasma to treat COVID-19, say former senior agency officials.

Aug 24, 2020 | 2:04 AM GMT

FDA Commissioner Stephen Hahn’s decisions and comments about granting Emergency Use Authorization for convalescent plasma to treat COVID-19 have put politics ahead of science, former senior FDA officials told BioCentury.

“At this moment in time, the FDA can no longer call itself an independent and science-based regulatory agency,” Luciana Borio, former acting FDA chief scientist, told BioCentury.

Borio, who served in the Trump administration as the National Security Council’s

Read the full 1306 word article